Photo taken from Andres Ricaurte Fajardo/X
Sep 9, 2024, 13:38
Andres Ricaurte Fajardo: How dural-based metastases can be distinguished from meningioma
Andres Ricaurte Fajardo, Molecular Imaging and Theranostics Researcher at Weil Cornell Medicine, shared a post on X:
“Thrilled to be part of this study highlighting how dural-based metastases rare yet significant in prostate cancer can be distinguished from meningioma, using Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET). This underscores the value of targeted PET in Prostate Cancer.
Congratulations Divya Yadav, Jana Ivanidze.”
PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer published in ScienceDirect.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 01:07
Nov 20, 2024, 01:00
Nov 20, 2024, 00:40
Nov 20, 2024, 00:31
Nov 20, 2024, 00:29
Nov 20, 2024, 00:23
Nov 20, 2024, 00:21